|
?:authorAffiliation
|
-
[\'HEC, Rue de la Libération 1, 78350, Paris, Jouy-en-Josas, France. alessandro.monaco@hec.edu.\', \'Grupo OAT Therapeutic Adherence Observatory, Observatorio de La Salud S.L, Madrid, Spain.\', \'Younger Lives Ltd, London, UK.\', \'Imperial College London, London, UK.\', \'UCIBIO/REQUIMTE Applied Molecular Biosciences Unit, Faculty of Pharmacy and Competences Center On Active and Healthy Ageing (Porto4Ageing), University of Porto, Porto, Portugal.\', \'Leiden University Medical Center LUMC-NL, Leiden, The Netherlands.\', \'Sechenov-Russia/ I.M. Sechenov First Moscow State Medical University, Moscow, Russia.\', \'C3 Collaborating for Health, London, UK.\', \'Italian National Institute of Health, Istituto Superiore Di Sanità , Rome, Italy.\', \'University of Brescia, Brescia, Italy.\', \'Esperity, Brussels, Belgium.\', \'KU, Leuven, Belgium.\', \'Geriatric Unit, Department of Medicine, University of Padua, Padua, Italy.\', \'Active Citizenship Network, Cittadinanzattiva APS, Rome, Italy.\', \'National and Kapodistrian University of Athens, Athens, Greece.\', \'Eurocarers, Brussels, Belgium.\', \'Upjohn (Pfizer), Brussels, Belgium.\', \'Viatris, Rome, Italy.\', \'Viatris, Brussels, Belgium.\', \'Viatris, Athens, Greece.\', \'Viatris, London, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}